Albert Grinshpun

3.0k total citations · 1 hit paper
43 papers, 829 citations indexed

About

Albert Grinshpun is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Albert Grinshpun has authored 43 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 14 papers in Genetics. Recurrent topics in Albert Grinshpun's work include Cancer Genomics and Diagnostics (11 papers), BRCA gene mutations in cancer (8 papers) and HER2/EGFR in Cancer Research (7 papers). Albert Grinshpun is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), BRCA gene mutations in cancer (8 papers) and HER2/EGFR in Cancer Research (7 papers). Albert Grinshpun collaborates with scholars based in Israel, United States and United Kingdom. Albert Grinshpun's co-authors include Tamar Peretz, Rinath Jeselsohn, Aviad Zick, Luna Kadouri, Ayala Hubert, Yakir Rottenberg, Dana G. Wolf, Iddo Z. Ben‐Dov, Myriam Maoz and Sean W. Fanning and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nature Biotechnology.

In The Last Decade

Albert Grinshpun

37 papers receiving 819 citations

Hit Papers

Life and death of circulating cell-free DNA 2019 2026 2021 2023 2019 100 200 300 400

Peers

Albert Grinshpun
Nathan Hunkapiller United States
Eric Q. Konnick United States
Kathryn N. Kurtzman United States
Stefan Pahl Germany
Daniza Mandich United States
Feng Ye China
Jennifer Ma United States
Nathan Hunkapiller United States
Albert Grinshpun
Citations per year, relative to Albert Grinshpun Albert Grinshpun (= 1×) peers Nathan Hunkapiller

Countries citing papers authored by Albert Grinshpun

Since Specialization
Citations

This map shows the geographic impact of Albert Grinshpun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Grinshpun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Grinshpun more than expected).

Fields of papers citing papers by Albert Grinshpun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Grinshpun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Grinshpun. The network helps show where Albert Grinshpun may publish in the future.

Co-authorship network of co-authors of Albert Grinshpun

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Grinshpun. A scholar is included among the top collaborators of Albert Grinshpun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Grinshpun. Albert Grinshpun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Grinshpun, Albert, Wen Ma, Giorgio Gaglia, et al.. (2024). Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer. npj Breast Cancer. 10(1). 42–42. 3 indexed citations
4.
Grinshpun, Albert, Shan Ren, Noah Graham, et al.. (2024). Phase Ib dose-escalation trial of taselisib (GDC-0032) in combination with HER2-directed therapies in patients with advanced HER2+ breast cancer. ESMO Open. 9(6). 103465–103465. 4 indexed citations
5.
7.
Diment, Judith, et al.. (2023). First Female Patient with a Rare CIC-FOXO4-Translocated Sarcoma: A Case Report. SHILAP Revista de lepidopterología. 16(1). 954–962. 1 indexed citations
8.
Morganti, Stefania, Heather A. Parsons, Nancy U. Lin, & Albert Grinshpun. (2023). Liquid biopsy for brain metastases and leptomeningeal disease in patients with breast cancer. npj Breast Cancer. 9(1). 43–43. 10 indexed citations
9.
Furth, Noa, Ekaterina N. Andreishcheva, Daniel Jones, et al.. (2022). Multiplexed, single-molecule, epigenetic analysis of plasma-isolated nucleosomes for cancer diagnostics. Nature Biotechnology. 41(2). 212–221. 56 indexed citations
10.
Lee, Ainsley Ryan Yan Bin, Lauren Shapiro, Astha Thakkar, et al.. (2022). Booster doses of COVID-19 vaccines for patients with haematological and solid cancer: a systematic review and individual patient data meta-analysis. European Journal of Cancer. 172. 65–75. 26 indexed citations
11.
Grinshpun, Albert, Tamar Hamburger, Tamar Sella, et al.. (2022). Breast Cancer with Low Recurrence Score on Oncotype DX©: Interplay Between Early Recurrence, Lobular Histology and BRCA Mutation. Oncology and Therapy. 10(2). 441–450. 2 indexed citations
12.
Grinshpun, Albert, et al.. (2022). ESR1 activating mutations: From structure to clinical application. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1878(1). 188830–188830. 28 indexed citations
13.
Grinshpun, Albert, et al.. (2022). The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer. Hematology/Oncology Clinics of North America. 37(1). 169–181. 12 indexed citations
14.
Grinshpun, Albert, Aviad Zick, Luna Kadouri, et al.. (2021). “High-Risk Breast Cancer Screening in BRCA1/2 Carriers Leads to Early Detection and Improved Survival After a Breast Cancer Diagnosis”. Frontiers in Oncology. 11. 683656–683656. 6 indexed citations
15.
Grinshpun, Albert, et al.. (2020). A Protracted Course of COVID19 Infection in a Metastatic Breast Cancer Patient During CDK4/6 Inhibitor Therapy. Frontiers in Oncology. 10. 1085–1085. 7 indexed citations
16.
Halpern, Naama, Albert Grinshpun, Ben Boursi, et al.. (2020). <p>Clinical Characteristics and Prognosis of Gastric Cancer Patients with <em>BRCA 1/2</em> Germline Mutations: Report of Ten Cases and a Literature Review</p>. OncoTargets and Therapy. Volume 13. 11637–11644. 7 indexed citations
17.
Grinshpun, Albert, et al.. (2019). Beyond KRAS: Practical Molecular Targets in Pancreatic Adenocarcinoma. Case Reports in Oncology. 12(1). 7–13. 14 indexed citations
18.
Goldberg, Rachel, Amichay Meirovitz, Esther Hermano, et al.. (2019). Regulation of Heparanase in Diabetes-Associated Pancreatic Carcinoma. Frontiers in Oncology. 9. 1405–1405. 5 indexed citations
19.
Grinshpun, Albert, Nancy Gavert, Roy Z. Granit, et al.. (2018). Ev vivo organ culture as potential prioritization tool for breast cancer targeted therapy. Cancer Biology & Therapy. 19(8). 645–648. 6 indexed citations
20.
Grinshpun, Albert, Naama Halpern, Roy Z. Granit, et al.. (2018). Phenotypic characteristics of colorectal cancer in BRCA1/2 mutation carriers. European Journal of Human Genetics. 26(3). 382–386. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026